ArticleBiomedicines2024

Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction.

Alexander Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.